Symposium introduction and overview adjuvant therapy of breast cancer: Perspectives for the '80s Joseph Allegra EditorialNotes Pages: S3 - S5
Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report Bernard Fisherother NSABP investigators EditorialNotes Pages: S7 - S17
Adjuvant chemotherapy in stage-II breast cancer: An overview of the NSABP clinical trials Norman WolmarkBernard Fishercontributing NSABP investigators EditorialNotes Pages: S19 - S26
Adjuvant therapy of breast cancer: The Southwest Oncology Group experience William A. Knight IIISaul E. RivkinRobert M. O'Bryan EditorialNotes Pages: S27 - S33
Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: Preliminary results—the ECOG experience P. P. Carbone EditorialNotes Pages: S35 - S38
Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients William C. WoodCALGB EditorialNotes Pages: S39 - S43
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast J. W. MeakinW. E. C. AlltR. D. Bulbrook EditorialNotes Pages: S45 - S48
Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The Southeastern Cancer Study Group experience Enrique Velez-GarciaMelvin MooreRichard Smalley EditorialNotes Pages: S49 - S60
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results Olof H. PearsonCharles A. Hubay24 participating investigators EditorialNotes Pages: S61 - S68
Prognostic factors in primary breast cancer Gary M. ClarkWilliam L. McGuire EditorialNotes Pages: S69 - S72
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications V. Craig JordanC. Chem EditorialNotes Pages: S73 - S86